Scientific Opinion on animal health risk mitigation treatments as regards imports of animal casings by EFSA Panel on Animal Health and Welfare
   EFSA Journal 2012;10(7):2820 
 
Suggested citation: EFSA Panel on Animal Health and Welfare (AHAW); Scientific Opinion on animal health risk mitigation 
treatments  as regards imports  of  animal  casings.  EFSA  Journal  2012;10(7):2820. [32  pp.] doi:10.2903/j.efsa.2012.2820. 
Available online: www.efsa.europa.eu/efsajournal  
 
© European Food Safety Authority, 2012 
SCIENTIFIC OPINION 
Scientific Opinion on animal health risk mitigation treatments as regards 
imports of animal casings
1 
EFSA Panel on Animal Health and Welfare (AHAW)
2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Salting with NaCl for 30 days is a well-established and accepted procedure in the casings industry and 
it has been the standard animal health risk mitigation treatment prescribed in EU legislation for many 
years. This opinion reviews (i) improvements in the NaCl treatment that would lead to an increased 
level of safety to avoid transmission of animal pathogens, (ii) alternative treatments that could have 
been developed giving equivalent or better results in the inactivation of relevant pathogens, and (iii) 
provides an assessment of the phosphate-salt treatment recommended by OIE for foot and mouth 
disease virus, in particular if it could be considered safe as regards the elimination of other animal 
pathogens. The rate of inactivation of viruses was highly dependent on temperature for both NaCl and 
phosphate-NaCl treatment. Treatment with phosphate-NaCl mixture leads to faster inactivation than 
treatment  with  NaCl  salt  alone.  Brucella  species  are  readily  inactivated  by  NaCl  salting,  but 
mycobacteria may survive beyond 30 days in intestines in conditions similar to those used for salting 
of casings. It is recommended that casings should be treated at 20 °C for 30 days to achieve effective 
inactivation of animal pathogens. Several other treatments have been applied to casings with the aim 
of inactivating infectious agents, but none of them have been extensively investigated with viruses 
relevant for animal health. © European Food Safety Authority, 2012 
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SUMMARY 
Following a request from the European Commission, the Panel on Animal Health and Animal Welfare 
(AHAW) was asked to deliver a scientific opinion on animal health risk mitigation treatments with 
regard to imports of animal casings. This request is limited to casings produced from intestines and 
bladders of animals of the bovine, ovine, caprine, porcine and equine species.  
Animal casings are imported into the European Union from a variety of third countries with different 
animal health status, provided that casings have been treated according to EU legislation (Commission 
Decision  2003/779/EC,  laying  down  animal  health  requirements  and  the  required  veterinary 
certification for  the  import  of  animal  casings  from  third  countries).  Salting  with  sodium  chloride 
(NaCl) for 30 days is a well-established and accepted procedure in the casings industry worldwide, 
and it has been the standard animal health risk mitigation treatment prescribed in EU legislation for 
many years, in order to eliminate any potential animal health risk from casings. Experience has shown 
that, under practical conditions, the EU prescribed treatment has effectively prevented the spread or 
introduction of animal diseases within or into the EU via animal casings. 
The request from the European Commission focused on the scientific review of: (i) improvements in 
the NaCl treatment that would lead to an increased level of safety to avoid transmission of animal 
pathogens; (ii) alternative treatments that could be developed, giving equivalent or better results in the 
inactivation  of  relevant  pathogens;  and  (iii)  assessment  of  the  modified  phosphate  salt  treatment 
recently recommended by the World Organisation for Animal Health for foot and mouth disease virus 
(FMDV), in particular whether it could be considered safe with regard to the elimination of animal 
health risks posed by pathogens other than FMDV possibly present in casings, taking into account the 
effects of both temperature and duration of treatment. 
The list of the infectious agents of concern for the import of casings into the EU was derived from 
legislation  on  import  of  fresh  meat  (if  not  treated,  intestines  are  considered  fresh  meat),  and 
comprised, among others, viruses causing FMD, classical swine fever (CSF) and African swine fever 
(ASF),  as  well  as  bacterial  infections  such  as  brucellosis,  tuberculosis  and  glanders.  Available 
practices  and  treatments  in  the  production  of  casings  were  reviewed,  and information  on  general 
biological characteristics related to survival or inactivation of the pathogens was collected. Scientific 
information dealing with the effect of treatments on the survival of the relevant pathogens in casings 
or in a collagen-matrix model was reviewed.  
For  most  of  the  infectious  agents  investigated,  salting  either  with  NaCl  or  with  phosphate-
supplemented NaCl showed higher efficacy at the upper range of temperature (about 20 ºC) than at 
4 ºC. 
FMDV in casings derived from experimentally infected animals was inactivated after treatment with 
NaCl for a period of 30 days at 20 ºC. However, after 30 days at 4 °C, some FMDV still remained 
infectious. Similar results were obtained with casings spiked with FMDV. In a three-dimensional (3D) 
matrix model the inactivation kinetics of FMDV in untreated and NaCl-salted samples was similar at 
the different temperatures tested, which emphasises the important role of temperature in inactivation. 
Treatment with a phosphate-supplemented NaCl led to faster inactivation of FMDV than treatment 
with NaCl salt alone, both in casings derived from experimentally infected animals as well as in 
spiked casings. For both NaCl and phosphate-supplemented NaCl treatment a temperature of 20 ºC 
was more effective than lower temperatures for inactivation.  
Salting of casings derived from experimentally infected animals with NaCl for a period of 30 days at 
room  temperature  (~20 °C)  leads  to  inactivation  of  CSFV.  However,  the  same  treatment  at  low 
temperature (4 ºC) does not fully inactivate the virus. In a 3D matrix model an effect of NaCl salting 
on virus inactivation compared with the untreated controls was evident at 20 °C and 25 °C but not at Treatments of animal casings 
 
EFSA Journal 2012;10(7):2820  3 
4 °C and 12 °C. Treatment with a phosphate-supplemented NaCl leads to complete inactivation of 
CSFV in casings derived from experimentally infected animals within 30 days. 
Regarding  ASFV,  no  studies  were  found  dealing  with  inactivation  on  experimentally  infected  or 
spiked  casings.  In  a  3D  matrix  model  ASFV  was  readily  inactivated  by  NaCl  salting  at  all 
temperatures (4, 12, 20 and 25 °C) after 21 days. However, from its general characteristics, ASFV can 
be regarded as more stable than CSFV. Therefore, these results should be interpreted with caution.  
There are no data available on inactivation of peste des petits ruminants virus and rinderpest virus on 
casings from experimentally infected animals, nor in spiked casings or in a 3D matrix model. From the 
general characteristics of these viruses it was assumed that they will be inactivated within 30 days at 
room temperature. 
For swine vesicular disease virus (SVDV) there are no studies on inactivation performed with NaCl 
salting at room temperature. Survival of virus for at least 200 days at 4 °C has been reported in porcine 
casings  preserved  with  NaCl.  In  a  3D  matrix  model  SVDV  showed  a  temperature-dependent 
inactivation, but, even at 20 °C with NaCl salting or 25 °C in untreated controls, some virus survived 
until day 30. Based on the general characteristics of SVDV, it is possible that NaCl salting for 30 days 
at room temperature will not completely inactivate the virus. 
Brucella spp.  are readily  inactivated  by  NaCl  salting,  but  Mycobacterium  avium  may  survive  far 
beyond 30 days in intestines in conditions similar to those used for salting of casings. M. bovis and 
other mycobacteria may show similar resistance to the salting treatment in casings, but this should be 
investigated.  
Several other treatments have been applied to casings with the aim of inactivating infectious agents, 
but  none  of them  have  been  extensively  investigated  with  viruses relevant for  animal  health.  No 
alternative  procedures  can  therefore  be  recommended  as  substitutes  for  current  salting  treatments 
based on NaCl and phosphate-supplemented NaCl. 
As there is a lack of specific scientific studies on the efficacy of bleaching and drying for pathogen 
inactivation  in  casings,  these  treatments  cannot  be  recommended  as  stand-alone  treatments,  i.e. 
without prior salting for 30 days. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION  
Animal casings
4 are imported into the European Union from a variety of third countries with different 
animal health status inter alia for use in the production of meat products like sausages. The animal 
health conditions for trade in and imports of casings are set up in Chapter 2 of Annex I to Council 
Directive  92/118/EEC  of  17  December  1992  laying  down  animal  health  and  public  health 
requirements governing trade in and imports into the Community of products not subject to the said 
requirements  laid  down  in  specific  Community  rules  referred  to  in  Annex  A(I)  to  Directive 
89/662/EEC and, as regards pathogens, to Directive 90/425/EEC
5. Commission Decision 2003/779/EC 
laying down animal health requirements and the veterinary certification for the import of animal 
casings from third countries
6 provides that Member States shall authorise the importation of animal 
casings derived from any species and from any third country accompanied by a health certificate 
certifying  inter  alia  that  those  casings  have  been  cleaned, scraped  and  either  salted  with  sodium 
chloride (NaCl) for 30 days, bleached or dried after scraping. Salting with NaCl for 30 days is a well-
established  and  accepted  procedure  in  the  casings  industry  worldwide  and  has  been  the  standard 
animal health risk mitigation treatment prescribed in Union legislation for many years in order to 
eliminate any potential animal health risk, in particular pathogens of animals of the bovine, ovine, 
caprine,  porcine  and  equine  species,  presented  by  animal  casings  imported  from  third  countries. 
Experience has shown that under practical conditions, the EU prescribed treatment has effectively 
prevented the spread or introduction of animal diseases within or into the EU via animal casings.  
In 2008, the World Organisation for Animal Health (OIE) introduced in Chapter 8.5 of its Terrestrial 
Animal Health Code (Code) a recommendation for the inactivation of foot-and mouth-disease virus 
(FMDV), if present in casings derived from ruminants and pigs. The recommended treatment consists 
of the exposure of the casing to either NaCl salt or a phosphate salt / NaCl mixture for at least 30 days 
at  a  room  temperature  of  about  20°C.  In  2011,  the  Member  States  of  the  EU  supported  the 
modification of that phosphate salt treatment and its temperature specification in the foot and mouth 
disease Code chapter
7. Furthermore, that phosphate salt treatment was also proposed for introduction 
in a modified code chapter on Classical Swine Fever (CSF) as a procedure for the inactivation of CSF 
virus (CSFV) if present in casings derived from pigs. However, that draft -modified chapter was not 
adopted in 2011 and various issues remain under further discussion. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION  
In accordance with Article 29(1)(a) of Regulation (EC) No 178/2002, the European Commission asks 
the European Food Safety Authority (EFSA) to provide a scientific opinion on whether 
1.  The NaCl treatment has been refined in recent years as regards temperature and/or duration of 
treatment in a way that would lead to an increased level of safety as regards animal pathogens, 
and 
2.  Alternative  treatments  have  been  developed  that  give  equivalent  or  better  results  in  the 
inactivation of pathogens possibly present in casings derived from animals of the bovine, 
ovine, caprine, porcine and equine species, taking into account scientific developments and 
technological progress.  
                                                       
4  The scope of this request for a scientific opinion shall be limited to casings produced from intestines and bladders of 
animals of the bovine, ovine, caprine, porcine and equine species. 
5  OJL062, 15.3.1993, p. 49. 
6  OJL285, 1.11.2003, p. 38. 
7  ―Article 8.5.41. Procedures for the inactivation of the FMD virus in casings of ruminants and pigs. For the inactivation of 
viruses present in casings of ruminants and pigs, the following procedures should be used: salting for at least 30 days either 
with dry salt (NaCl) or with saturated brine (Aw < 0.80), or with phosphate supplemented dry salt containing 86.5 percent 
NaCl, 10.7 percent Na2HPO4 and 2.8 percent Na3PO4 (weight/weight/weight), and kept at a temperature of greater than 
12 ºC during this entire period.‖ [2011 edition of the Code] Treatments of animal casings 
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Furthermore, considering that the OIE, in its Code chapter on FMD, has recently recommended a 
modified phosphate salt treatment as an alternative to the standard NaCl treatment for the inactivation 
of FMDV, if present in casings derived from ruminants and pigs, EFSA is requested to provide a 
scientific opinion on whether 
3.  modified  phosphate  salt  treatment,  when  applied  to  casings  derived  from  animals  of  the 
bovine, ovine, caprine, porcine and equine species, can be considered as an effective and 
reliable alternative to the standard NaCl treatment currently foreseen in Union legislation, so 
as to provide at least equivalent animal health guarantees as regards the elimination of animal 
health risks posed by pathogens other than FMDV possibly present in casings derived from 
animals of the bovine, ovine, caprine, porcine and equine species, taking into account the 
effects of both the temperature and the duration of treatment. 
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ASSESSMENT 
1.  Introduction 
1.1.  Focus of the work 
This opinion focuses on the treatments for casings and their ability to inactivate relevant infectious 
agents that could be present in casings. Traditionally, treatments to produce animal casings include 
cleaning, scraping and salting at room temperature for a period of at least 30 days. Other less frequent 
treatments also authorised for the import of casings into the European Union and performed after 
cleaning and scraping are drying (normally done after the salting procedure) or bleaching (referred to 
as blanchir in French with the meaning ―to bleach‖ or ―to treat with heat‖). Casings may be produced 
form several hollow organs and from a variety of species, but, for the purpose of this mandate, only 
casings derived from the intestines and urinary bladder of cattle, sheep, goats, swine and horses are 
considered. If originating in authorised establishments, and treated by any of the approved procedures 
(Council  Directive  92/118/EEC  and  Commission  Decision  2003/779/EC),  animal  casings  may  be 
imported into the EU regardless of the animal health status of the country of origin or production of 
casings. Trading of casings under these conditions is considered to be safe, and there is not a single 
recorded incident of animal pathogens entering the EU farm animal population that is attributable to 
contaminated casings. Scientific information was reviewed to assess the ability of classic and new 
alternative treatments (such as the sodium phosphate–NaCl treatment) to inactivate possible infectious 
agents present in casings. Only relevant infectious agents that are of concern in relation to the trade of 
fresh  meat  under  EU  legislation  (Commission  Regulation  (EU)  No  206/2010,  Annex  II)  were 
considered.  
1.2.  Work approach  
1.2.1.  Methodology  
In responding to this mandate the AHAW Panel focused on the scientific assessment of information on 
treatments of casings against specific pathogens causing animal diseases in line with the requested 
mandate rather than a thorough risk assessment on the risk of their introduction into the EU.  
A critical review of the literature obtained by a broad scope  search and provided by the hearing 
experts was used to extract relevant information. The flow of the work followed the structure of this 
document:  (i)  determine  the  list  of  the  pathogens  of  concern  for  the  EU  related  to  casings  with 
justifiable reasons; (ii) review available practices and treatments for production of casings; (iii) collect 
information, through literature and other sources, on biological characteristics related to the survival or 
inactivation  of  the  pathogens;  and  (iv)  assess  the  effects  of  available  and  new  treatments  on  the 
survival of the relevant pathogens in casings. The basic biological features of the pathogens were 
collected  from  well-known/-recognised  sources  (scientific  documents,  reference  textbooks,  World 
Organisation for Animal Health (OIE) Manual, etc.). Specific outcomes of various treatments were 
based on information available from published literature. Differentiation was made between studies on 
casings derived from experimentally infected animals and those involving in vitro experiments. Some 
assumptions were made, and it is stated when information for a pathogen has been extrapolated from 
other infectious agents with similar physicochemical characteristics.  
1.2.2.  Identification  of  relevant  infectious  agents  that might  be  present in  casings  derived 
from animals of the bovine, ovine, caprine, porcine and equine species  
There  is  no  specific  EU legislation identifying  infectious agents  that  might  be  present in  casings 
derived from animals of the bovine, ovine, caprine, porcine and equine species. Council Directive 
82/894/EEC of 21 December 1982 on the notification of animal diseases within the Community lists 
in Part A of Annex I the diseases of terrestrial animals that are notifiable. In total, 22 infectious 
diseases are currently listed, all of which are traditionally considered to have a major impact not only 
on animal health but also on trade or human health (zoonotic character). The epizootic diseases subject Treatments of animal casings 
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to mandatory emergency actions with territorial restrictions are listed in Annex C of Council Directive 
90/425/EEC  of  26  June  1990,  concerning  veterinary  and  zootechnical  checks  applicable  in  intra-
community trade of certain live animals and products with a view to the completion of the internal 
market. Several of the listed diseases are irrelevant when it comes to the role of casings in their 
transmission.  For  example  pathogens  of  poultry,  bacterial  infections,  parasitic  agents,  vector-
transmitted pathogens and zoonotic agents are not transmitted via casings, and animal casings do not 
contribute to the spread of these infections. 
Infectious agents relevant for this opinion are those listed in the EU legislation concerning import of 
fresh meat (Commission Regulation (EU) No 206/2010 of 12 March 2010 laying down lists of third 
countries, territories or parts thereof authorised for the introduction into the European Union of certain 
animals and fresh meat and the veterinary certification requirements). This Regulation is an important 
legal document, which identifies relevant pathogens that might also be introduced by the trade of 
casings. Annex II of this Regulation lays down model veterinary certificates for the import of fresh 
meat that indicate potential animal health pathogens that might be present in fresh meat derived from 
animals of the bovine, ovine, caprine, porcine and equine species are indicated. The same infectious 
agents identified for fresh meat have been also considered for animal casings. 
For bovine, ovine and caprine meat under ―Animal Health attestation‖ the following diseases are 
included: 
  foot and mouth disease (FMD) 
  rinderpest  
  tuberculosis 
  ovine or caprine brucellosis. 
For pork under ―Animal Health attestation‖ the following diseases are mentioned: 
  FMD 
  classical swine fever 
  African swine fever 
  rinderpest 
  swine vesicular disease 
  porcine brucellosis. 
For equine meat under ―Animal Health attestation‖ the following diseases are mentioned 
  African horse sickness  
  glanders. 
From the above-listed diseases in the certificates for import of fresh meat, rinderpest, African Horse 
sickness and glanders can be ignored regarding the role of casings in their transmission. Rinderpest 
was eradicated worldwide in 2011, and therefore it does not play a role any more. However, a close 
relative of the rinderpest virus (RPV), the peste des petits ruminants virus (PPRV) is still present in 
many countries of the world and might play a role as an important pathogen in casings. As the general 
properties of both viruses are more or less identical in respect of their tenacity and survival time, it Treatments of animal casings 
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appeared appropriate to include peste des petits ruminants instead of rinderpest in the list of diseases 
that might be transmitted via casings. Therefore, the properties of PPRV will be discussed under the 
chapter on RPV. 
Most  bacterial  species,  including  the  ones  that  may  be  present  in  the  gastrointestinal  tract  of 
ruminants, cannot survive a water activity (aw) less than 0.91 (Wijnker, 2009) The casings industry 
uses either dry salt (aw 0.75) or saturated brine (aw between 0.75 and 0.80) for preservation and a 
normal storage period of 30 days.  
Studies have demonstrated that growth of Brucella abortus and B. melitensis is completely inhibited at 
a concentration of 4 % sodium chloride (NaCl), far less than the concentrations of NaCl (10–40 %) in 
casings traded internationally (Houben, 2005). Furthermore, B. abortus and B. melitensis have been 
shown not to survive beyond 25 days in sterilised sea water (Mitscherlich and Marth, 1984), with a 
salt concentration also less than that used to preserve casings. In a risk assessment from New Zealand 
(MAF  Biosecurity  New  Zealand,  2010)  it  was  concluded  that  the  likelihood  of  Brucella  species 
entering the country in sheep or goat casings is negligible.  
Palásek et al. (1991) reported the survival of mycobacteria in salted pigs’ guts for up to 7 months in an 
experiment in which only the mucosa of the intestines was removed. At +4 °C and near-saturation of 
salt Mycobacterium avium survived for 7 months in salted guts vs. 35 days in unsalted guts. Thus, a 
six-fold increase in survival time was observed after the salting procedure. If other mycobacteria, like 
M. bovis or M. avium subsp. paratuberculosis, display a similar  stabilising effect after salting, it 
cannot be ruled out that bovine casings, in which part of the mucosal lymphoid tissue still remains 
after cleaning and scraping, could pose a potential risk for introduction of  these mycobacteria. In 
general,  bovine  tuberculosis  of  the  digestive  system  is  uncommon,  but  in  some  areas  alimentary 
tuberculosis in cattle may be more common due to husbandry practices (Ameni et al., 2006). Further 
data on the influence of salting on mycobacteria should therefore be sought in order to be able to 
assess the risk of their introduction by casings. 
African horse sickness (AHS) is a serious arthropod-borne viral disease of horses and other equids, 
which  can  result  in  significant  morbidity  and  mortality  in  susceptible  populations.  AHS  virus 
transmission occurs exclusively by the bite of competent arthropod vectors. An exception to this is the 
infection of dogs via ingestion of meat from infected animals. However, from the pathogenesis of 
AHS, it is not expected that casings will play a role in the transmission of the virus, and therefore no 
particular attention has been given to this disease. 
Glanders (infection by Burkholderia mallei) is mainly a disease of equids, affecting the nasal cavity 
and lungs, and eventually the skin (farcy). In glanders, the digestive and urinary tracts are not affected, 
and casings do not pose a risk for transmission of this infection.  
Vesicular stomatitis virus (VSV) is not quoted in the above list, but it causes a disease with clinical 
signs similar to those of FMD. Although in cattle, horses and swine, high titres of VSV are found at 
the margins of lesions and in vesicular fluids for a short period after infection (Scherer et al., 2007), 
viraemia  is  undetectable  in  other  tissues  including  muscle,  brain,  liver,  spleen,  mesenteric  lymph 
nodes, kidneys and spinal cord (USAHA Grey Book, 2008). This indicates that transmission of VSV 
by meat is not likely. The potential for VSV transmission by other animal products has not been 
addressed in the literature (EFSA Journal 2012;10(4):2631). Those findings place the virus outwith the 
scope of the current mandate.  
The import of animal casings into the EU also has to fulfil the requirements of the legislation on 
transmissible spongiform encephalopathies (TSEs), which establishes a country risk classification and 
related requirements for import and considers certain tissues from bovine, ovine and caprine animals 
as specified risk material (SRM), having to be removed from the food and feed chain to protect the 
health of consumers against the risk of bovine spongiform encephalitis (BSE) (Regulation (EC) No Treatments of animal casings 
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999/2001). It was agreed that TSEs are excluded from the scope of the current work. Furthermore, 
previous EFSA opinions have assessed the risks of TSEs associated with casings.
8  
2.  Production of casings  
All domestic ungulates farmed for food purposes can be used as a source of animal casings. However, 
casings are predominantly produced from pigs (―hog casings‖
9), sheep and goats (―sheep casings‖) and 
cattle (―beef casings‖). From pigs, cattle and sheep the entire intestinal tract is used for the production 
of casings, with the exception of the ileum in cattle, which is not used. Beef casings are also produced 
from  the  urinary  bladder  (Ockerman  and  Hansen,  2000)  and  from  the  oesophagus  (―weasand‖). 
However, that part is outwith the scope of the current mandate.  
After processing, the submucosa of the intestine is the remaining layer in hog and sheep casings. A 
cleaned sheep casing is on average 0.11 mm thick, whereas a cleaned hog casing is about 0.32 mm 
(Bartenschlager-Blässing, 1979; Koolmees and Houben 1997). In contrast to hog and sheep casings, 
beef casings retain all the original intestinal layers after cleaning. 
From horses only the large intestines are processed into casings, with the exclusion of the caecum. 
This is mostly done by hand and all layers remain identifiable (personal communication, ENSCA 
2012). 
In Europe, the species available for production of animal casings are limited to porcine, ovine, caprine 
and equine animals, as cattle intestines are listed as a SRM in accordance with TSE Regulation (EC) 
No 999/2001. Therefore, any animal casings of bovine origin are imported into the EU only from 
countries with a negligible risk status for BSE, as defined by OIE . 
The  import  of  animal  casings  into  the  EU  is  covered  by  Council  Directive  92/118/EEC  and 
Commission  Decision  2003/779/EC,  laying  down  the  animal  health  and  veterinary  certification 
requirements for the import of animal casings from third countries. All third country establishments 
from which casings originate have an implemented hazard analysis and critical control point (HACCP) 
system, are subjected to Food and Veterinary Office (FVO) inspection and are approved for the import 
of animal casings into the EU.
10 Some of the countries from whic h significant amounts of animal 
casings are imported into the EU are endemically infected with FMD with a high disease prevalence, 
e.g. China, Colombia, Egypt, India, Iran and Pakistan. 
In 2011,  the European Natural Sausage Casings Association (ENSCA)  presented their Community 
Guide to Good Practice for hygiene and the application of the HACCP principles in the production of 
natural sausage casings (ENSCA, 2012). This document was prepared in accordance with Article 9 of 
Regulation (EC) No 852/2004 of the E uropean Parliament and of the Council on the  Hygiene of 
Foodstuffs, and it was subsequently endorsed by the Standing Committee on the Food Chain and 
Animal Health (SCOFCAH). It is available on the website of DG SANCO (link). Although this 
document is mainly intended for the European casing industry , it is also used extensively by the 
international casing industry. Its aim is to assist in the implementation of the European Hygiene 
Package and HACCP principles according to the Codex Alimentarius.
11  
The treatments prescribed for animal casings imported into the EU are specified in Commission 
Decision 2003/779/EC and include cleaning, scraping and salting with NaCl for 30 days.  In an 
alternative to the salting procedure, casings may be dried or bleached
12 after cleaning and scraping. 
                                                       
8  http://www.efsa.europa.eu/en/efsajournal/doc/464.pdf; http://www.efsa.europa.eu/en/efsajournal/pub/1317.htm 
9  The terms in the section are broadly recognised and used by the casings industry and indicated in the ENSCA  Guide to 
Good  Practice   available  on  the  website  of  DG  SANCO  
(http://ec.europa.eu/food/food/biosafety/hygienelegislation/good_practice_en.htm). 
10 https://webgate.ec.europa.eu/sanco/traces/output/non_eu_listsPerActivity_en.htm  
11 Accessed online http://www.codexalimentarius.org/ on 29 May. 
12 Referred to as blanchir in French with the meaning of ―to bleach‖ or ―to treat with heat‖. Treatments of animal casings 
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The use of approved procedures other than salting with NaCl is anecdotal and irrelevant for the actual 
casing industry. There is only one report of animal casings treated by an actual bleaching process, 
using peracetic acid (US patent 2,966,415), but this procedure was never applied in practice. Recently, 
a variation of the NaCl salting procedure, with the addition of phosphate salts has been tested and 
recommended,  along  with  the  classic  NaCl  treatment,  to  inactivate  FMDV  present  in  casings  of 
ruminants and pigs (OIE Terrestrial Animal Health Code, 2011). Therefore, only NaCl salting and the 
modified phosphate salting procedures will be considered further.  
See Annex 1 for a more detailed description of the production of casings.  
2.1.  Salt treatment  
Traditional salting with NaCl for at least 30 days has been the main preservation procedure for animal 
casings for many years. NaCl is added either as dry salt or using fully saturated brine (aw 0.75).
13 This 
treatment is accepted as the industr y’s standard operating procedure (SOP) for the preservation of 
animal casings (ENSCA, 2012) and is included in the OIE’s Terrestrial Animal Health Code as the 
reference treatment for casings to avoid the introduction of FMDV via casings. The effectiveness of 
this treatment has been extensively investigated against the vegetative phase of bacteria (Gabis and 
Silliker, 1974; Houben, 2005; Wijnker et al., 2006) but information on its effectiveness in inactivating 
other relevant animal viruses is scarce (see Table 1).  
The temperature at which the salted casings are preserved and the duration of the treatment may have 
an effect on the inactivation of infectious agents, as shown by the different outcomes of treatments in 
Table 1. Most recent studies (Wieringa-Jelsma et al., 2011) have compared different temperatures 
representative of refrigeration (4 ºC) and room temperature (20–21 ºC). It is generally accepted that a 
duration of 30 days is sufficient for inactivation of viruses in casings. For example, FMDV is fully 
inactivated after this period, provided that preservation is done at room temperature (20 ºC) (Wijnker 
et al., 2007, 2012). However, inactivation of other viruses such as CSFV was not achieved after 30 
days if the temperature of preservation was 4 ºC (Depner et al., 1998). Few or no recent references 
could  be  found  for  other relevant  ungulate  and  equine  viruses.  For  swine  vesicular  disease  virus 
(SVDV), a classic reference (McKercher et al., 1974) stated that SVDV is still present after NaCl 
salting after 200 days of storage at 39 °F (4 °C). There are no data on the effect of this standard 
treatment on ASFV, VSV or PPRV. 
Table 1:  Salting treatments for casings and their effect on the infectivity of relevant animal 
viruses 
                                                       
13 Brine is a solution of salt (usually sodium chloride) in water. In different contexts, brine may refer to salt solutions ranging 
from about 3.5 % (a typical concentration of sea water or the lower end of solutions used for brining foods) up to about 
26 % (a typical saturated solution, depending on temperature). At 100 °C (373.65 K, 212 °F), saturated sodium chloride 
brine is about 28 % salt by weight, i.e. 39.12 g salt dissolves in 100 mL of water at 100 °C. At 0 °C (273.15 K, 32 °F), 
brine can hold only about 26 % salt (Handbook of Chemistry and Physics, 63rd edition 1982–1983). 
Agent 
Animal/ 
product  Treatment  Result  Reference 
FMD  Bovine  and 
porcine 
intestines 
(untreated) 
Storage at –30 °C 
Storage at 2–4 °C 
Present at day 120 
Absent after 48 h 
Savi et al., 1961 
FMD  Bovine 
intestine 
(untreated) 
Storage at 4 °C  Absent after day 6  Cottral, 1969 
FMD  Sheep casing  Dry salted for 14 days at 
4 °C 
Present at day 14  Böhm  and  Krebs, 
1974 Treatments of animal casings 
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CSF, classical swine fever; FMD, foot and mouth disease; SVD, swine vesicular disease. 
Specific studies on the efficacy of drying or bleaching of casings to inactivate animal viruses were not 
found.  
2.2.  Phosphate treatment (salting with the addition of phosphates) 
The initial studies using phosphates for treatment of casings (Bakker et al., 1999; Houben, 2005) 
showed a clear improvement on different microbial and mechanical properties of animal casings, and 
prompted  further  studies  to  show  the  inactivation  properties  of  this  modified  salting  procedure. 
Treatment consists of traditional salting with phosphate-supplemented NaCl, either as dry salt or using 
fully  saturated  brine.  The  phosphate-supplemented  salt  contained  86.5 %  NaCl,  10.7 %  Na2HPO4 
(molecular weight 142) and 2.8 %, Na3PO4 (molecular weight 164) (wt/wt/wt). The efficacy of this 
treatment for the inactivation of viruses has been investigated in animal casings for FMDV and CSFV 
(Wijnker et al., 2007, 2008, 2012; Wieringa-Jelsma et al., 2011). These studies have shown that the 
correct combination of NaCl plus phosphate salts, temperature and treatment time can remove the risk 
of  infectivity  of  different  viruses  from  treated  animal  casings  (Table  2).  The  NaCl–phosphate 
treatment showed an advantage over the classic salting procedure, being effective against FMDV and 
CSFV to some extent also at 4 ºC. At present the treatment of casings of ruminant or porcine origin 
using either salt or phosphate-supplemented salt for a minimum of 30 days and at a temperature above 
12 ºC is recommended by the OIE for the inactivation of FMDV present in casings (OIE Terrestrial 
Animal Health Code, Chapter 8.5—Foot-and-mouth disease, Article 8.5.41). 
Table 2:  Salting—phosphate  salt  treatment  of  casings  and  effect  on  infectivity  of  relevant 
animal viruses 
CSF, classical swine fever; FMD, foot and mouth disease. 
FMD  Sheep,  hog 
and  beef 
casings 
Dry salted for 30 days at 
4 or 20 °C 
Present at day 30 when 
stored at 4 °C 
Absent at day 30 when 
stored at 20 °C 
Wijnker  et  al.,  2007, 
2012 
SVD  Hog casings  Saturated  brine,  storage 
at 4 °C 
Present after day 200  McKercher  et  al., 
1975 
CSF  Hog casings  Brine soak 4 °C for 20 h, 
water  soak  44 °C,  dry 
salted and storage at 4 °C 
Absent at day 12  Helwig  and  Keast, 
1966 
Water  soak  21 °C  for  3 
days,  dry  salted  and 
storage at 4 °C 
Present at day 86 
Water  soak  21 °C  for 
23 h, +42 °C for 1 h, dry 
salted and storage at 4 °C 
Absent after day 9 
CSF  Hog casings  Saturated  brine  for  30 
days at 4 °C 
Present at day 30  Depner, 1998 
Agent 
Animal/ 
product  Treatment  Result  Reference 
FMD  Sheep,  hog 
and  beef 
casings 
Dry  salted  using 
phosphate–salt  for  30 
days at 4 or 20 °C 
Absent at day 30 when 
stored at 4 or 20 °C 
Wijnker  et  al.,  2007, 
2012 
CSF  Hog casings  Dry  salted  using 
phosphate–salt  for  30 
days at 4 or 20 °C 
Present  at  day  15  but 
absent at day 30 when 
stored at 4 or 20 °C 
Wijnker et al., 2008 Treatments of animal casings 
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2.3.  Other potential alternative treatments  
Several treatments have been applied to casings with the aim of inactivating relevant viral pathogens. 
In a classic experiment, intestines of experimentally FMDV-infected sheep were treated with the NaCl 
salting procedure, and shown to contain infectious FMDV after 14 days at 4 ºC. The authors then 
assessed the additional inactivating effect of low pH on FMDV by using citric acid (2 %) or lactic acid 
(0.5 %) on the 14-day salted casings, obtaining a full inactivation with any of the two treatments even 
after 5 minutes.  
In another study, as a part of a broader experiment, a citrate-supplemented salt solution containing 
89.2 % NaCl, 8.9 % trisodium citrate dehydrate and 1.9 % citric acid monohydrate (wt/wt/wt), with 
pH 4.5  was  applied  to  casing  made  from  pigs  infected  with  CSFV,  at  two  different  preservation 
temperatures (4º C and 20 ºC) and two time points (15 days and 30 days) (Wijnker et al., 2008). The 
treatment was successful in removing infectivity only after 30 days, and only when casings were 
preserved at 20 ºC.  
Ozone in water has been recently used as an alternative system of treatment of casings with the aim of 
reducing bacterial contamination (Benli et al., 2008). This treatment was found to be only partially 
effective, with a reduction in bacterial counts after treatment for 2 hours. Longer treatments reduced 
the quality and other properties of the casings. The authors concluded that other methods should be 
investigated (e.g. irradiation, with an electron beam or a gamma radiation source).  
 
Gamma irradiation has been tested with pork and lamb casings for the reduction or elimination of 
bacterial contamination. The irradiation treatment significantly reduced microbial contamination in a 
dose-dependent manner (Byun et al., 2001; Jo et al., 2002; Trigo et al., 2003; Chawla et al., 2006), and 
when  combined  with  a  previous  washing  step  with  distilled  water  it  eliminated  microbial 
contamination  (Byun  et  al.,  2001).  In  general,  it  can  be  concluded  from  these  studies  that  this 
treatment is useful to improve the microbial quality of casings, without adverse effects on quality 
characteristics.  
There are many reports on the use of different substances for the treatment of animal casings, e.g. 
organic acids (Sakata et al., 1998; Nishiumi et al., 2005), phosphate salts (Schwanz and Schnackel, 
2007; Sakata et al., 2008), sodium carbonate (Schwanz and Schnäckel, 2007), or beer and brewer’s 
grains (Sakata et al., 2011). The main purpose of these treatments was to improve the casings with 
regard to quality, e.g. tenderness, resistance or gliding properties, but the studies did not generate 
information about the microbiological quality of the casings.  
There is a patent on the treatment of animal casings by bleaching with peracetic acid and neutralisation 
with sodium bicarbonate (US patent 2,966,415, Dec. 27, 1960), but no pathogen inactivation data were 
provided  and  the  procedure  was  probably  never  applied  in  practice  owing  to  concerns  about  the 
negative effects of low pH values on the technological properties of the casings. 
3.  General properties of relevant viral pathogens  
3.1.  Foot and mouth disease virus 
FMD is a highly contagious disease of cloven-hooved animals, which can have devastating economic 
consequences.  FMDV  is  a  member  of  the  family  Picornaviridae,  genus  Aphthovirus,  and  can  be 
divided into seven immunologically distinct serotypes: A, O, C, SAT1, SAT2, SAT3, and Asia1, 
which do not confer cross-immunity.  
As a non-enveloped virus it is stable to organic solvents. It is preserved by refrigeration and freezing 
but progressively inactivated by temperatures above 50 °C. Heating animal products to a minimum 
core temperature of 70 °C for at least 30 minutes inactivates the virus. It is stable only at a relatively 
narrow range of pH values and quickly inactivated by pH < 6.0. Values above pH > 9.0 will also lead 
to inactivation. Therefore suitable disinfectants are, for example, sodium hydroxide (2 %), sodium Treatments of animal casings 
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carbonate (4 %), citric acid (0.2 %) and acetic acid (2 %). Also sodium hypochlorite (3 %), potassium 
peroxymonosulphate/sodium  chloride  (1 %)  and  chlorine  dioxide  will  inactivate  FMDV,  but 
iodophores,  quaternary  ammonium  compounds  and phenol  will  not,  especially  in  the  presence  of 
organic matter (OIE FMD Technical Disease Card). 
The concentrations and survival of FMDV in animal tissues and, in particular, in animal products was 
extensively reviewed by Ryan et al. (2008), who emphasized that the inactivation of FMDV by pH and 
temperature  change  is  biphasic.  Bachrach  et  al.  (1957),  for  example,  showed  that  the  initial 
inactivation followed first-order kinetics, but at 55 ºC, 61 ºC, pH 5 and pH 6, a residual fraction of 
virus, 10
–6 of the initial concentration, remained which was very resistant to further inactivation. The 
inactivation-resistant fraction of FMDV must be taken into account when estimating the efficiency of 
thermal  or  pH-dependent  reduction  of  virus  load.  The  significance  of  this  residual  fraction  of 
infectious virus is related to the initial virus load in the animal product in question, and may vary 
considerably depending on the nature of the product and the treatment it undergoes. Proteins and lipids 
may have a protective effect on the virus. While the virus survives in lymph nodes and bone marrow at 
neutral pH, it is destroyed in muscle at pH < 6.0 i.e. after rigor mortis. The virus survives drying and 
may persist for days to weeks in organic matter in moist conditions and cool temperatures. 
In order to interpret reports on the survival of FMDV in a particular matrix (buffer, media, organic 
tissues, etc.) or products, one has to consider the starting titres, which are often not stated. Of course, 
higher  starting  concentrations  mean  that  it  will  take  longer  until  no  residual virus  can  be  found. 
Furthermore, the methods for assaying the infectivity differ. While some authors inoculated the virus 
intradermally or into the tongue of cattle, most used various cell culture systems and the results are 
usually given either as tissue culture infective dose (TCID50) per gram or mL or as plaque-forming 
units (PFUs) per gram or mL. Assuming comparable sensitivity of the cell culture system, 1 PFU 
equals about 1.4 TCID50.  
Nevertheless, based on the extensive review of virus survival in organs and animal products derived 
from experimentally infected animals provided by Ryan et al., (2008), it can be stated that the highest 
titres  can  be  found  in  affected  areas  of  the  skin  (clinically  infected  pigs:  up  to  10
10 TCID50/g, 
(Alexandersen et al., 2001), whereas in most tissues, titres in the range of 10
4 to 10
6 TCID50/g were 
found. During the viraemic phase, a blood
14 titre of 10
5.6 PFUs/mL was reported by Cottral (1969) for 
cattle, while a blood titre of 10
7.2 ID50/g was reported by Sellers (1971) for pigs and a blood titre of 
10
5.0 PFUs/mL by Burrows (1968) for sheep. The maximum titres in organs where, to our current 
knowledge, no significant virus amplification occurs (e.g. the small and large intestines used for the 
production of casings), is probably dependent on the blood titres during viraemia. From the data 
compiled by Ryan et al. (2008), it can be concluded that infective virus can still be found in animal 
tissues  and  products  where  high  starting  titres  can  be  assumed  after  several  months  at  low 
temperatures (below 0 ºC or 4 ºC) and after 1 month at ambient temperatures, e.g. 20 ºC. 
3.2.  Classical swine fever virus 
CSFV is a small enveloped positive single-stranded RNA virus that belongs to the genus Pestivirus of 
the Flaviviridae family (Becher et al., 1999). As an enveloped virus, CSFV is inactivated by organic 
solvents  (ether  or  chloroform),  detergents  (Nonidet  P40,  deoxycholate,  saponin),  chlorine-based 
disinfectants,  phenolics  and  quaternary  ammonium  aldehydes  (formaldehyde,  glutaraldehyde) 
(reviewed by Edwards (2000)). CSFV is known to survive for prolonged periods in a favourable 
environment—cool, moist, protein-rich—as found, for example, in meat and intestines (casings). The 
survival of the virus is highly influenced by the environmental temperature and matrix in which it is 
located/found. In general it can be stated that survival of the virus increases when the temperature is 
low and where the environment is rich in proteins (such as in casings) and moist. CSFV is relatively 
stable between pH 5 and 10. Stability is extended at lower pH values, but the degree of stability is, to a 
certain extent, strain dependent (Depner et al., 1992).  
                                                       
14 Reported as ―blood titres‖, but tests may have been carried out with serum as usual. Treatments of animal casings 
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The increased stability at low temperatures, even at low pH (pH 4), and in protein-rich environments is 
important, as these are conditions encountered during storage of meat, meat products, intestines, etc. 
During the commercial production of pork and pork products, the time and temperature of storage 
seldom allow the pH to fall below 5.7 (Farez and Morley, 1997) and therefore provide ideal survival 
conditions. Survival up to 4.5 years in frozen meat has been reported (Edgar et al., 1952). The most 
important factors are the temperature applied during the processing and its duration (Edwards, 2000). 
Survival rates in processed meat products of, for example, 90 days in salami (Savi et al., 1961) and 
126 days in Iberian loins (Mebus et al., 1993) have also been reported. For a more extensive review of 
the survival rates in processed meat products, see Farez and Morley (1997).  
As previously mentioned, thermal inactivation is strongly influenced by the matrix in which the virus 
is located. However, in vitro studies have shown that inactivation takes less than 1 minute at 100 °C, 2 
minutes at 90 °C, 3 minutes at 80 °C and 5 minutes at 70 °C. Inactivation at 56 °C was shown to be 
more heterogeneous and strain dependent (reviewed by Edwards, 2000). In blood inactivation at 69 °C 
it took at least 30 minutes. Alternative methods of inactivation have also been developed. Ultra-violet 
light, hydrostatic pressure or a combination of both has been shown to be able to effectively inactivate 
CSFV (Freitas et al., 2003). Similarly, vapour-phase hydrogen peroxide has been shown to be an 
efficacious way for decontaminating material (Heckert et al., 1997).  
3.3.  African swine fever virus 
ASFV belongs to the genus Asfivirus and is the unique member of the Asfarviridae family (Pringle, 
1999).  It  is  a  large  icosahedral  and  enveloped  double-stranded  DNA  virus.  ASFV  shares  some 
characteristics with large DNA viruses (Poxviridae, Iridoviridae). 
ASFV is very resistant to inactivation in environmental conditions. For example, contaminated pig 
pens in the tropics were shown to remain infectious to domestic pigs for 3 days (Montgomery, 1921, 
cited in Wardley et al., 1983). The virus can be isolated from sera or blood kept at room temperature 
for 18 months.  
ASF virus is inactivated by heat treatment at 60 °C for 30 minutes (Mebus et al., 1997) and by many 
solvents that disrupt lipid bilayers and by commercial disinfectants (1 % formaldehyde in 6 days, 2 % 
NaOH in 1 day). Paraphenylphenolic disinfectants are very effective. ASFV can survive over long 
periods (months or years) when frozen or stored at 4 °C (Dixon, 2005). Infectivity is stable over a 
wide pH range. Some infectious virus may survive treatment at pH 4 or pH 13. 
In  meat  products,  ASFV  may  persist  for  several  weeks  or  months  in  frozen  or  uncooked  meat 
(Wilkinson,  1989).  In  products  prepared  by  curing,  such  as  Parma  ham,  viral  infectivity  was not 
demonstrated  in  ham  300  days  after  processing  and  curing  (Farez  and  Morley,  1997).  The  virus 
survived for 140 days in Iberian and Serrano hams and for 112 days in loin. However, in these curing 
processes,  virus  inactivation  occurs  before  the  products  are  released  for  marketing.  No  infectious 
ASFV has been found in cooked or canned hams when processed at 70 °C.  
3.4.  Rinderpest virus and peste des petits ruminants virus  
Although rinderpest is mentioned in the animal health attestation of the import certificates for fresh 
meat of the EU (Commission Regulation (EU) No 206/2010), the disease does not play any further 
role as it was eradicated globally in 2011. However, a close relative of the RPV, the PPRV is still 
present in many countries of the world and might play a role as an important pathogen in casings.  
RPV  and  PPRV  are  members  of  the  Morbillivirus  genus  within  the  family  Paramyxoviridae 
(Kingsbury et al., 1978). The virions are pleomorphic particles with a lipid envelope enclosing a 
ribonucleo-protein core, which contains the genome, a single-stranded RNA of negative polarity. The 
RPV virions have a maximum diameter of 300 nm while those of PPRV are larger with a mean 
diameter of 400 500 nm (Bourdin and Laurent-Vautier, 1967; Gibbs et al., 1979). Treatments of animal casings 
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RPV does not persist outside the host for more than few hours at normal temperature. It is heat and 
light sensitive. However, it is relatively resistant to cold and may survive for 1 month in blood kept 
under refrigeration. The RPV is stable between pH 7.2 and 8.0, relatively stable between pH 4.0 and 
10.2 and is rapidly inactivated at lower and higher pH values. RPV is readily destroyed by heat, drying 
and most disinfectants, including lipid solvents. In general it can be stated that survival of the virus 
increases when the temperature is low. The half-life of RPV in spleen or lymph nodes has been 
calculated to be 5 minutes at 56 °C, 105 minutes at 37 °C, 6.4 hours at 25 °C and 2.3 days at 4–7 °C 
(Plowright,  1968).  Assuming  that  in  intestines  the  initial  virus  load  would  be  below  or  about 
10
5.0 TCID50 the virus would be inactivated in about 4 days if the pH was neutral and the storage 
temperature about 25 °C. The tenacity of PRRV is similar to RPV. Lefevre (1982) calculated a half-
life of about 2 hours at 37 °C; at 50 °C infectivity was destroyed within 30 minutes. 
3.5.  Swine vesicular disease virus 
 
SVD is a disease of pigs caused by a virus of the family Picornaviridae. All isolates are classified in a 
single serotype, with four distinguishable antigenic/genomic variants. SVD was included in the list of 
diseases notifiable to the OIE because of the similarity of its lesions to those produced by FMD; 
however SVD is often mild in nature and may infect pigs subclinically. Most recent SVD outbreaks 
have  been  subclinical,  and  SVD  can  rarely  be  diagnosed  now  on  the  basis  of  clinical  signs, 
necessitating laboratory diagnosis (Bellini et al., 2007, 2010). Pigs can be infected by contact or by 
exposure  to  an  infected  environment  (Dekker  et  al.,  1995).  Movement  of  subclinically  infected 
animals is the most common means of spreading SVDV. 
The virus is remarkably stable in the pH range of 2.5–12.0. It can be inactivated by sodium hydroxide 
combined with detergent. Direct treatment of swine waste with 1.5 % (w/v) NaOH or Ca(OH)2 for 30 
minutes  can  inactivate  SVDV  at  either  4° C  or  22° C.  A  mixture  of  didecyldimethylammonium 
chloride and 0.1 % NaOH for 30–60 minutes was also efficient. For personal disinfection and in the 
absence of gross organic matter, oxidising agents, iodophores and acids are suitable if combined with 
detergents. SVDV is preserved by refrigeration and freezing, but inactivated by a temperature of 56 °C 
for 1 hour (OIE SVD Technical Disease Card).  
In cured meat products (e.g. ham and salami) derived from experimentally infected animals, the virus 
could still be found after several hundred days (McKercher et al., 1974; Mebus et al., 1993). While 
Hedger and Mann (1989) found feeding of waste food an important source of infection through the 
ingestion of contaminated meat (15 %), swill feeding does not appear to have played a role in recent 
epidemics, and thus its importance is unclear (EFSA Journal 2012;10(4):2631) 
4.  Studies with casings from experimentally infected animals  
4.1.  Foot and mouth disease virus 
Böhm and Krebs (1974) not only reported FMDV titres of up to 2.5 log10 TCID50/mL in casings of 
experimentally infected sheep even after storage for 14 days at 4 °C, but they also confirmed the 
efficacy of a 5-minute treatment with 0.5 % citric or lactic acid on infected sheep casings to inactivate 
FMDV.  However,  as  the  industry  considered  this  treatment  detrimental  to  the  technological 
parameters of the casings, it was never adopted as a standard procedure.  
McKercher  et  al.  (1978,  1980)  mentioned  that  residual  infective  FMDV  remains  in  untreated 
processed casings for as long as 250 days. Unfortunately, they did not provide information on the 
processing and storage of these casings (temperature, pH, salting). From earlier reports of experiments 
carried out by McKercher et al. (1974) with FMDV and SVDV in casings, it appears that the casings 
had been stored in saturated NaCl brine at 39 °F (4 °C).  
Wijnker et al . (2007) investigated whether the alkaline phosphate salt brine suggested by the industry 
as a new standard treatment option for casings would inactivate FMDV in a different way from the 
usual  neutral  NaCl  brine.  At  a  pH  of  10,  they  found  for  cell  culture  virus  a  reduction  of Treatments of animal casings 
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3 log10 TCID50/mL within 120 minutes. However, the inactivation of FMDV is biphasic, and lipids and 
proteins may protect the virus. Furthermore, owing to the buffer capacity of the proteins present in 
casings, the pH of 10 may not be consistently reached under practical conditions. Therefore, these in 
vitro  data  are  of  limited  value.  In  order  to  elucidate  whether  FMDV  in  casings  would  survive 
standardised industrial procedures, Wijnker et al. (2007) used casings derived from pigs and sheep 
experimentally infected with FMDV to study virus survival in casings. While the highest titres found 
in cleaned large intestines after slaughter were similar to those reported by Böhm and Krebs in 1974 
(10
3.0 PFUs/mL in ovine and 10
2.56 PFUs/mL in porcine samples), in small intestines most samples 
were negative and only one ovine sample had a titre of 10
2.0 PFUs/mL. The casings were treated with 
either  NaCl  or  a  mixture  of  phosphate  salts  and  NaCl  (86.5 %  NaCl;  2.8 %  sodium  phosphate 
(Na3PO4, molecular weight 164) and 10.7 % sodium hydrogen phosphate (Na2HPO4, molecular weight 
142). They were stored for 30 days at either 4 °C or 20 °C. Although after storage at 20 °C with either 
salt,  no  remaining  infectivity  was  found,  after  30  days  at  4 °C,  3  out  of  12  samples  of  casings 
examined per treatment group still contained virus, irrespective of the salt used. As the initial virus 
titres in most samples were too low, no inactivation kinetics could be generated with these samples. It 
was also not entirely clear whether the results obtained with porcine and ovine casting would apply to 
bovine casings.  
Wijnker et al. (2012) carried out a further study with casings of infected bovines, using the same salts 
as described above. Six cattle were infected by tongue inoculation with strain A Iran 97 and on days 2, 
3 and 4, two animals were slaughtered, casings produced according to standard procedures and the 
initial (pre-salting) virus titres determined. However, only in seven samples taken from three out of six 
cattle (on a total of 30 samples) could FMDV be isolated, directly after stunning, exsanguination and 
processing, prior to salt treatment. The infectivity titres in cleaned casings were close to the detection 
limit (about 10 TCID50/mL) and neither exact quantification nor the generation of an inactivation 
kinetic was possible. Samples (n = 30) were taken on days 1, 3, 5, 7, 14 and 30 and examined for 
FMDV. No FMDV could be isolated in any bovine samples treated with phosphate-supplemented salt 
and stored at 4 °C and 20 °C at any time point. In NaCl salt, the virus survived longer. On day 1 after 
storage in NaCl salt, FMDV could be isolated in three samples stored at 20 °C (no samples were 
stored at 4 °C on day 1). On day 3 after storage in NaCl salt, FMDV could be isolated in two samples 
stored at 4 °C and one sample stored at 20 °C. At later time points, virus could be isolated only from 
samples stored in NaCl salt at 4 °C: FMDV was found in one sample on day 5, in four samples on day 
7, in one sample on day 14 and in one sample on day 21. On day 30, none of the bovine samples 
stored in NaCl were found to contain any FMDV. 
The experiments in sheep, pigs and cattle can be summarised by stating that only low virus titres were 
found in cleaned intestines derived from animal infection experiments. Intestines are embryologically 
of endodermal origin and are neither primary sites of infection nor secondary sites of replication 
(Alexandersen et al., 2003) and thus the virus found was probably derived from the small remaining 
volumes of viraemic blood. No virus could be found after 30 days at 20 °C. 
4.2.  Classical swine fever virus  
Only a few studies have been conducted to determine the survivability and resistance of CSFV in 
casings. Most studies have involved meat and meat products without particular consideration of the 
casings.  
From data regarding the tenacity of CSFV in general it is known that the virus is relatively stable 
within a pH range of 5–10 and at room temperature (~ 20 °C). A study conducted on the thermal and 
pH stability of cultured CSFV strains revealed a mean half-life of 50 hours at neutral pH and 20 °C 
and a mean half-life of 260 hours at pH 4 and 4 °C. If these findings are extrapolated to CSFV-
infected casings, it can be concluded that the virus will survive a storage period of 30 days at 4 °C but 
will be inactivated at 20 °C. Theoretically, if in casings the initial virus load were below or about 
10
5.3 TCID50 the virus would be inactivated in about 30 days if the pH were neutral and the storage 
temperature about 20 °C (standard preservation treatment with NaCl for casings). Unfortunately, no Treatments of animal casings 
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studies have been performed with infected casings under exactly these temperature and pH conditions. 
Depner at al. (1998) conducted a study in which it was shown that CSFV can survive in casings when 
stored in saturated brine (neutral pH) for a period of 30 days at 4 °C. This study highlights that at 4 °C 
the stability of CSFV is prolonged. So it can be concluded that storage of CSFV-infected casings 
below 20 °C for 30 days at a neutral pH does not necessarily lead to a complete inactivation of the 
virus.  
Wijnker  et  al.  (2008)  treated  CSFV-infected  casings  with  phosphate-supplemented  or  citrate-
supplemented NaCl to increase or decrease the pH respectively. Such treated casings were stored for 
30 days at either 4° C or 20 °C. After 15 days of storage CSFV could be isolated in all samples. After 
30 days of storage the casings were fed to susceptible pigs and CSF infection was confirmed only in 
the animals that received casings treated with citrate-supplemented salt and stored at 4 °C.  
4.3.  Swine vesicular disease virus 
McKercher et al. (1974) reported that SVDV survived for at least 200 days in processed intestinal 
casings derived from SVDV-infected animals and stored in saturated NaCl brine at  39 °F (4 °C). 
Mebus et al. (1993), apparently referring to the same set of samples, reported a survival time of 780 
days.  
5.  Experimental studies with casings that had been spiked with virus after slaughter 
Casings derived from experimentally infected animals always had too low virus titres to generate 
proper inactivation kinetics. In order to generate such inactivation kinetics for FMDV in casings, 
Wijnker et al. (2012) ―spiked‖ samples of casings with high-titre FMDV. Although these spiking 
experiments cannot completely mimic the situation in animal casings, as the virus is contained in cell 
debris,  not  in  a  tissue  matrix,  the  conditions  for  virus  inactivation  (e.g.  pH,  protein  and  lipid 
concentrations) were certainly closer to those in casings than in experiments with cell culture-derived 
virus suspended in brine. Two experiments using high-titre vesicular material derived from cattle 
infected with FMDV strain A Iran 97 were conducted. The first experiment was conducted over a 15-
day period. As in the experiments with infected animals, the casings were treated with either NaCl or 
the mixture of phosphate salts and NaCl and stored at either 4 °C or 20 °C. A temperature-dependent 
virus inactivation was found in oesophagus, jejunum, colon and bladder samples.  
Treatment with NaCl and storage at 4 °C resulted in a decline in virus titre of around 2 log10 in 15 
days, and no FMDV titre could be determined after day 13. Treatment with NaCl and storage at 20 °C 
resulted in a steeper decline in virus titre, with no FMDV titre determined after day 9. 
Treatment with phosphate salt and storage at 20 °C resulted in rapid inactivation, with no virus found 
at any time point; storage at 4 °C resulted in a similar reduction with no FMDV titre determined after 
day 9. 
As the last time points at which virus could be isolated were close to the end of the experiment, the 
authors repeated the experiment with spiked jejunum and caecum samples that were then stored for 55 
days, attempting to elucidate whether the apparently linear inactivation kinetics would also apply to 
longer storage times. Again, samples were stored at 20 °C and 4 °C in either NaCl or phosphate salt. 
This time, samples were taken every 5 days. Treatment with NaCl and storage at 4 °C resulted in an 
inactivation of about 3 log10 in 55 days, whereas storage at 20° C resulted in complete inactivation 
within 15 days, the last virus being detected on day 10, indicating a reduction of around 6 log10. 
Treatment  with  phosphate-supplemented  NaCl  and  storage  at  4 °C  or  20 °C  resulted  in  complete 
inactivation of the virus by day 5. 
In order to elucidate whether the inactivation kinetic observed with strain A Iran 97 applies also to 
other FMDV strains, similar experiments were carried out with strains A Turkey 06, C Oberbayern Treatments of animal casings 
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and O Manisa. Colon and caecum samples were stored over a period of 35 days. For strains A Turkey 
06 and C Oberbayern, an inactivation kinetic could be determined for storage in NaCl brine at 4 °C.  
Treatment with NaCl and storage at 4 °C resulted in virus inactivation of around 2 log10. After 30 
days, FMDV could still be determined. 
Treatment with NaCl and storage at 20 °C resulted in rapid inactivation, with no virus found on day 3 
or beyond. 
Treatment  with  phosphate-supplemented  NaCl  and  storage  at  either  temperature  resulted  in  rapid 
inactivation with no FMDV found on day 3 or beyond. 
FMDV of strain O1 Manisa could not be isolated on day 3 or beyond, irrespective of treatment or 
storage, and no kinetic could be generated. It is unclear whether this difference actually reflects a 
property of the strain. 
6.  Experimental studies with a 3D collagen matrix model for animal casings  
Owing to the limitations of the simple ―spiking‖ model additional experiments with a 3D collagen 
matrix model were carried out (Wieringa-Jelsma et al. 2011). In this one study a 3D collagen matrix 
model  for  animal  casings  was  used  to  determine  the  inactivation  of  four  viruses  causing  highly 
contagious diseases in livestock: FMDV, CSFV, SVDV and ASFV. 
Cells infected with the four viruses mentioned above were embedded in a bovine collagen type I gel 
matrix in order to investigate the effect of storage without salt (untreated), storage in NaCl and storage 
in phosphate-supplemented NaCl at four different temperatures (4, 12, 20 and 25 °C) over a period of 
30  days.  As  expected,  the  results  showed  that  all  four  viruses  were  inactivated  faster  at  higher 
temperatures. At lower temperatures the inactivation curves of the four viruses differed, and often the 
influence of the salt could also be observed. 
6.1.  Foot and mouth disease virus 
For  FMDV  the  influence of  temperature  was  clearly  seen  in  the  untreated  FMDV  samples,  with 
increasing inactivation rates at increasing temperatures. The detection limit of 1.8 log10 TCID50/mL 
was reached after 21, 7, 3 and 2 days of incubation at 4, 12, 20 and 25 °C, respectively, equivalent to a 
reduction of 3.2 log10 TCID50. Incubation with NaCl at the different temperatures resulted in curves 
that were similar to those for the untreated FMDV samples.  
In contrast to the NaCl and untreated samples, the phosphate salt-treated samples showed biphasic 
inactivation  curves.  At  all  temperatures,  a  period  of  rapid  inactivation  by  about  2.5 log10 TCID50 
within 24 hours was followed by a period in which FMDV titres remained constant. The reduction of 
FMDV titres by phosphate salt treatment was significantly higher than the control treatment during the 
first 7, 3, 2 and 1 days of incubation at 4, 12, 20 and 25 °C, respectively. At storage temperatures of 
20 °C and 25 °C, FMDV titres were higher in the phosphate salt samples than in the untreated and 
salt-treated samples for 5 and 4 days, respectively, although these differences were not significant. 
Because of the biphasic inactivation kinetics, no linear regression analysis was performed and no D-
values calculated. 
6.2.  Classical swine fever virus 
Phosphate-supplemented salt treatment increased the effect that temperature had on inactivation of 
CSFV. The salt treatment only increased CSFV inactivation at the higher temperatures (20 °C and 
25 °C). The influence of treatment temperature on CSFV titres was also observed with the untreated 
CSFV samples, with increasing inactivation rates at increasing temperatures. However, the detection 
limit  of  1.4 log10 TCID50/mL  was  only  reached  on  day  21  at  25 °C  after  a  reduction  of 
5.8 log10 TCID50. At temperatures of 4 °C and 12 °C no significant additional inactivation effect of the 
salt treatment over the control was observed. The results of the salt treatment were comparable with 
the untreated samples, as also indicated by the D-values. However, at 20 °C and 25 °C, treatment with Treatments of animal casings 
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salt  resulted  in  significantly  greater  virus  reduction.  Highly  significant  virus  inactivation  by 
phosphate-supplemented salt was observed at all temperatures for the entire period of incubation (30 
days), except on days 21 and 30 at 25 °C, when the untreated samples had reached the detection limit. 
The phosphate-supplemented salt showed the lowest D-values, confirming this inactivation method as 
the most effective for inactivating CSFV. 
6.3.  African swine fever virus 
ASFV was the most stable virus, even at higher temperatures. However, both NaCl and phosphate salt 
were able to inactivate ASFV. At 4 °C, low titres were still observed after NaCl treatment up to day 
15,  while  phosphate  salt  treatment  resulted  in  titres  reaching  the  detection  limit  of 
1.4 log10 TCID50/mL by day 2 at all temperatures, which means a reduction in AFSV titre of at least 
2.2 log10 TCID50/mL. 
6.4.  Swine vesicular disease virus 
SVDV showed a temperature-dependent inactivation, but, even at 25 °C, some virus survived until day 
30 in the untreated samples. While NaCl treatment resulted only in a limited additional inactivation of 
SVDV, phosphate salt treatment had a significant additional inactivation effect at all temperatures 
compared with control samples. However, even with phosphate salt treatment, the detection limit was 
only reached after 15 days of incubation at 25 °C. 
 
Table 3:  D-values of four viruses embedded in a 3D collagen matrix after 30 days of treatment 
by various inactivation methods 
Virus   Temperature (°C) 
D-value (days/r
2) of various treatments 
Untreated   Salt (NaCl)   Phosphate salt
a 
FMDV  4  NA
b  NA  NA 
12  NA  NA  NA 
20  NA  NA  NA 
25  NA  NA  NA 
CSFV  4  35/0.88  36/0.67  8/0.92 
12  16/0.97  10/0.90  6/0.66 
20  7/0.97  5/0.90  3/0.72 
25  4/0.97  3/0.89  1/NA
c 
SVDV  4  76/0.45  26/0.87  9/0.75 
12  9/0.97  7/0.98  9/0.58 
20  5/0.95  5/0.86  4/0.69 
25  4/0.87  3/0.86  1/0.82 
ASFV  4  44/0.34  10/0.37  1/NA 
12  54/0.53  1/NA  1/NA 
20  29/0.50  1/NA  1/NA 
25  25/0.84  1/NA  1/NA 
D-value is the time required in days to reduce the viral population by a factor of 10
1. 
r
2 is the correlation coefficient of the regression analysis for calculating the D-value. 
ASFV, African swine fever virus; CSFV, classical swine fever virus; FMDV, foot and mouth disease virus; SVDV, swine 
vesicular disease virus. 
aPhosphate salt is phosphate-supplemented salt. 
bNot applicable because D-values could not be determined. 
cInput data for regression analysis did not include the ones reaching the detection limit. An exception was made for data 
reaching the detection limit immediately after day 0. 
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CONCLUSIONS 
GENERAL CONCLUSIONS  
  The survival time of FMDV depends on a number of factors including the matrix (e.g. buffer, 
media, tissue), temperature and pH value.  
  In experimentally infected sheep, pigs and cattle only low FMDV titres were found in cleaned 
intestines prior to salting. 
  CSFV  is  relatively  stable  at  a  pH  range  of  5–10  at  temperatures  up  to  20 °C.  Raising  the 
temperature dramatically reduces the survival of the virus, as does changing the pH to below pH 5 
or above pH 10. Increased stability is favoured by protein-rich environments. 
  ASFV can be regarded as relatively stable. It can survive over long periods (months or years) 
when stored at 4 °C. Infectivity is stable over a wide pH range, and it may survive treatment at 
pH 4 or pH 13. In meat products, ASFV may persist for several weeks or months in frozen or 
uncooked meat 
  The tenacity of PPRV and RPV are similar. While they are relatively stable at a neutral pH, both 
viruses are rapidly inactivated at low and high pH values. The survival of the virus increases when 
the temperature is low.  
  It  appears  likely  that  SVDV  will  survive  for  prolonged  periods  of  time  if  kept  below  room 
temperature. 
CONCLUSIONS FOR TOR1 
  The efficacy of salting with NaCl for a period of 30 days at room temperature (20 ºC) is well 
documented for inactivation of FMDV in casings derived from experimentally infected animals. 
However, after 30 days at 4 °C, some FMDV survived.  
  The  experiments  with  FMDV  ―spiked‖  casings  revealed  a  linear  temperature-dependent 
inactivation of virus during the observation period. Inactivation occurred more rapidly at 20 °C, 
and no virus could be found after storage in saturated NaCl for 30 days at this temperature. 
However, at 4 °C infective virus was still present. 
  In a 3D matrix model the detection limit of FMDV in untreated samples was reached after 21, 7, 3 
and  2  days  of  incubation  at  4,  12,  20  and  25 °C,  respectively,  equivalent  to  a  reduction  of 
3.2 log10 TCID50. Treatment with NaCl at the same temperatures resulted in similar inactivation 
kinetics, which emphasises the role of temperature in inactivation. 
  Salting of casings derived from experimentally infected animals with NaCl for a period of 30 days 
at room temperature (~20 °C) inactivated CSFV. However, the same treatment at low temperature 
(4º C) was not fully efficacious in terms of inactivating the virus.  
  In a 3D matrix model the detection limit of CSFV of 1.4 log10 TCID50/mL was first reached on day 
21 at 25 °C and on day 30 at 20 °C. An additional effect of NaCl salting on virus inactivation 
compared with the untreated controls was evident at 20 °C and 25 °C but not at 4 °C and 12 °C. 
  There  are  no  data  available  on  inactivation  of  ASFV  from  experimentally  infected  or  spiked 
casings.  Treatments of animal casings 
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  In a 3D model ASFV was readily inactivated by NaCl salting at all temperatures (4, 12, 20 and 
25 °C) after 21 days. However, from its general characteristics, ASFV can be regarded as more 
stable than CSFV. Therefore these results should be interpreted with caution.  
  There are no data available on inactivation of PPRV and RPV on casings from experimentally 
infected  animals,  in  spiked  casings  or  in  a  3D  matrix  model.  However,  from  the  general 
characteristics of these viruses it could be assumed that they will be inactivated within 30 days at 
room temperature. 
  For SVDV there have been no studies of inactivation with NaCl salting at room temperature. 
Survival of the virus for at least 200 days at 4 °C has been reported in casings, preserved with 
NaCl,  derived  from  experimentally  infected  pigs.  In  a  3D  matrix  model  SVDV  showed 
temperature-dependent inactivation, but even at 20 °C with NaCl salting or 25 °C in untreated 
controls, some virus survived until day 30.  
  Based on the general characteristics of SVDV, it is possible that NaCl salting for 30 days at room 
temperature will not completely inactivate the virus. 
  Brucella spp. are readily inactivated by NaCl salting, but M. avium may survive well beyond 30 
days in intestines in conditions similar to those used for the salting of casings. It is probable that 
M. bovis and other mycobacteria may show similar resistance to the salting treatment in casings, 
but this needs to be investigated.  
  For most of the infectious agents investigated, NaCl salting showed greater efficacy at the upper 
range of temperature (20 ºC and above) than at 4 ºC. 
CONCLUSIONS FOR TOR2 
  Several treatments have been applied to casings with the aim of inactivating infectious agents, but 
none of them has been extensively investigated with viruses relevant to animal health.  
  Acid treatments with either lactic (0.5 %) or citric (2 %) acid  on casings previously salted for 14 
days were enough for full inactivation of FMDV after only 5 minutes. A similar treatment with 
citrate-supplemented salt solution was successful in removing CSFV infectivity only after 30 days, 
and only when casings were preserved at 20 ºC. However, these treatments led to a significant loss 
in quality of the product. Studies with other viruses were not found. 
  Ozone in water has been shown to be only partially effective against bacterial contamination in 
casings. No studies have been performed with viruses.  
  Gamma  irradiation  has  been  tested  with  natural  pork  and  lamb  casings  for  the  reduction  or 
elimination of bacterial contamination. This treatment may be useful for improving the microbial 
quality of casings, without having adverse effects on quality characteristics, but it has not been 
tested in casings derived from animals experimentally infected with the relevant viruses.  
  There are many reports on the use of other substances for treatment of animal casings, with the 
purpose of improving the quality of the casings, but they do not address the issue of pathogen 
inactivation.  
CONCLUSIONS FOR TOR3  
  In  casings  derived  from  experimentally  infected  animals,  as  well  as  in  spiked  casings,  the 
treatment  with  phosphate-supplemented  NaCl  often  led  to  faster  inactivation  of  FMDV  than 
treatment with NaCl salt alone. Also, with the phosphate treatment, a temperature of 20 ºC was 
more effective than lower temperatures for inactivation.  Treatments of animal casings 
 
EFSA Journal 2012;10(7):2820  23 
  In contrast to the studies with actual casings, with phosphate-supplemented salt, a biphasic virus 
(FMDV) inactivation was seen in the 3D matrix model, with low levels of virus surviving at 12 °C 
until day 21.  
  Treatment with phosphate-supplemented salt resulted in effective inactivation of CSFV in casings 
derived from experimentally infected animals within 30 days.  
  For most of the infectious agents investigated,  phosphate-supplemented salt treatment showed 
greater efficacy at the upper range of temperature (20 ºC or above) than at 4 ºC. 
RECOMMENDATIONS 
TOR1 
Salting with NaCl for 30 days should be done at 20 ºC or above to achieve effective inactivation of 
infectious agents. 
Further data on the influence of salting on mycobacteria should be sought in order to be able to 
assess the risk of their introduction by casings. 
TOR2 
Owing to a lack of data no alternative procedures can be recommended as substitutes for current 
salting treatments based on NaCl and phosphate-supplemented salt. 
Owing to a lack of specific scientific studies on the efficacy of bleaching and drying for pathogen 
inactivation, these treatments cannot be recommended as stand-alone treatments, i.e. without prior 
salting for 30 days. 
TOR3 
Salting with phosphate-supplemented salt for 30 days should be done at 20 ºC or above to achieve 
effective inactivation of infectious agents. 
The 3D collagen matrix should be evaluated as a suitable model for assessing the efficacy of 
treatments for the inactivation of infectious agents, as a replacement for animal experiments. 
   Treatments of animal casings 
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APPENDIX 1—PRODUCTION OF CASINGS 
DESCRIPTION OF SOURCE SUBSTANCE  
All domestic ungulates farmed for food purposes can be used as a source for animal casings. However, 
they are predominantly produced from pigs (―hog casings‖
15), sheep and goats (―sheep casings‖) and 
cattle (―beef casings‖). 
From  pigs  the  entire  intestinal  tract  is  used  for  the  production  of  casings,  specifically  the  small 
intestines  including  the  duodenum,  jejunum,  ileum,  caecum  (known  as  ―bung‖),  large  intestines 
including the colon ascendens, colon transversum (―chitterling‖), colon descendens (―after end‖) and 
rectum (―fat end‖). From sheep, the small intestines are used, particularly the duodenum and jejunum 
and sometimes also the ileum and caecum. 
The intestinal tract of cattle is also used entirely with the exception of the ileum. Its shape differs too 
much from the jejunum to produce the classic ―beef rounds‖ and is therefore removed prior to the 
cleaning process and destroyed. Beef casings are produced from the small intestines including the 
duodenum and jejunum (―beef rounds‖) and the caecum and from the large intestines, including the 
entire colon (―beef middles‖). Beef casings are also produced from the urinary bladder (Ockerman and 
Hansen, 2000) and the oesophagus (―weasand‖). However, that part is outwith the scope of the current 
mandate. 
Although there is quite a large variety in the shapes and sizes of the intestinal tract among the different 
species used for casing production, their basic anatomy and function are remarkably similar. The 
intestinal wall is composed of four basic layers (Figure 1). 
 
Figure 1:   Schematic diagram of sheep small intestine showing mesentery and serosa (a), 
inner and outer muscle layers (b), submucosal blood vessels (c), muscularis mucosae (d), 
submucosa (e), lymphoid nodule (Peyer’s patch) (f), and tunica mucosa (villus and crypt 
layers) (g). The tunica mucosa, the muscularis, the serosa and Peyer’s patches are removed 
during processing, so the animal casing consists of only the submucosa (e) (From Koolmees 
et al., 2004).  
 
                                                       
15 The terms in the chapter are broadly recognised and used by the casings industry and indicated in the ENSCA Guide to 
Good  Practice  available  on  the  website  of  DG  SANCO  
(http://ec.europa.eu/food/food/biosafety/hygienelegislation/good_practice_en.htm). Treatments of animal casings 
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The tunica serosa is the outermost layer covering the intestinal tract. The tunica muscularis consists of 
two layers of smooth muscle, with an inner layer in a circular and an outer layer in a longitudinal 
orientation.  The  tunica  submucosa,  lying  beneath  the  tunica  muscularis,  has  a  microstructure 
characterized by a network of collagen fibres (type I), elastin and blood vessels of different sizes 
(Nishiumi and Sakata, 1999). For hog and sheep casings, this submucosa is the remaining layer of the 
intestine after processing and forms the natural sausage casing (Figure 2). 
 
Figure 2:   Fully processed sheep casing. Photograph courtesy of Dr J.J. Wijnker. 
The tunica mucosa is the innermost layer of the intestinal tract and lines the lumen. Embedded in the 
mucosa  lies  lymphatic  tissue,  which  occurs  irregularly  along  the  length  of  the  small  intestine  as 
isolated lymphoid nodules (lymphonoduli solitarii) but tends to be most prominent in the ileum. These 
aggregated  lymphoid  nodules  (lymphonoduli  aggregati)  are  known  as  Peyer’s  patches  and  are 
anatomically  located  on  the  convex  side  of  the  intestine  opposite  to  the  mesenteric  attachment 
(Wijnker, 2009). 
 
Taking a sheep casing as example, Figure 3 shows the full thickness of the uncleaned small intestine 
and  figure  4  shows  the  tunica  submucosa  as  remaining  tissue  layer  after  the  cleaning  process  is 
finished. A cleaned sheep casing is on average 0.11 mm thick, whereas a cleaned hog casing, also 
comprising only of the submucosa, is 0.32 mm (Bartenschlager-Blässing 1979; Koolmees and Houben 
1997). 
 
 
Figure 3:   Sheep casing, before cleaning showing mesentery and serosa (a), inner and 
outer muscle layers (b), lymphoid nodule (Peyer’s patch) (c), submucosa (d) and mucosa (e) 
(picrosirius red staining). 
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Figure 4:   Sheep casing, after cleaning showing submucosa (picrosirius red staining). 
From Koolmees et al., 2004. 
 
PROCESSING  
As described by Wijnker (2009), the subsequent cleaning process of porcine and ovine (caprine) small 
intestines can vary between species and the geographical location of the cleaning operation. Clear 
differences exist in how the intestines are pulled from the viscera, being either with a knife, by hand or 
by  machine.  Contrary  to  hog  casings,  sheep  casings  are  usually  fermented  prior  to  the  cleaning 
process. After the faeces have been removed from the intestines, sheep casings are placed overnight in 
cooled storage during which the mucosa will degrade for easier removal. 
In general for hog and sheep casings, the faeces are removed from the small intestines, the mucosa is 
crushed and removed in various steps and the outer layers (the tunica muscularis and tunica serosa) 
are  scraped  off,  leaving  the  tunica  submucosa  as  the  actual  animal  casing  (Fischer  and 
Schweflinghaus, 1988; Ockerman and Hansen, 2000). However, during the cleaning process the actual 
collagen/elastin structure of the animal casing is not altered, nor during the subsequent curing and final 
preservation using salt as preservative agent (either dry salted or in saturated brine). 
Large-scale manual cleaning of hog casings is no longer used around the world, as it has become more 
economical  to  use  only  mechanical  processing.  Koolmees  et  al.  (2004)  used  sheep  casings  to 
determine whether there was a difference in the efficacy of cleaning between manual and mechanical 
processing techniques. Results showed, however, that no significant differences existed between the 
techniques and that no lymphatic tissue (Peyer’s patches) remained after cleaning. Apart from the 
apparent absence of differences in cleaning efficacy, subsequent selection and grading of the cleaned 
casings  would  not  allow  any  tissue  residues  to  remain  in  the  final  product.  Therefore,  making  a 
distinction on whether animal casings were manually or mechanically cleaned is not relevant with 
respect to quality or product safety parameters. 
The porcine large intestines are mostly processed into ―hog chitterlings‖ and ―fat ends‖ by hand. All 
layers remain identifiable, whereas it depends on the operation if the mucosa is (partially) removed 
(Schweigmann and Seeger, 1988; Ockerman and Hansen, 2000). 
Equine small intestines are not used for casing production at all; only the large intestines are processed 
into horse casings, with the exclusion of the caecum. Similar to the porcine large intestines, processing 
is mostly done by hand and all layers remain identifiable (personal communication, ENSCA 2012). 
In contrast to the extensive processing of hog and sheep small intestines into casings, beef casings 
retain all original layers after cleaning (Figure 5). Similar to sheep and hog casings produced from the 
small  intestines,  beef  casings  are  processed  mechanically  too.  Several  studies  (Koolmees,  1998; 
Botka-Petrak et al., 2001; Wijnker et al., 2008) on the histology of beef casings have shown that, 
although most of the tunica mucosa is removed from the small intestines, the tunica muscularis and 
serosa can be clearly identified and the Peyer’s patches also remain present.  Treatments of animal casings 
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Figure 5:   Beef casing, after cleaning (haematoxylin–eosin staining) with remains of a 
lymphoid nodule (Peyer’s patch) (a) embedded in mucosa, submucosa (b), muscular layers 
(c) and serosa (d). From Wijnker et al., 2008. 
 
MARKET DESCRIPTION OF CASINGS 
In Europe, the species available for the production of animal casings are limited to porcines, ovines, 
caprines and equines, as cattle intestines are listed as SRM in accordance with the TSE Regulation 
(EC) No 999/2001. Therefore, any animal casings of bovine origin are imported into the EU only from 
countries with a negligible risk status for BSE, as defined by OIE . 
In 2011, approximately 252 million pigs and 52 million sheep and goats were slaughtered in the EU 
Member states (EU Commission, DG AGRI). It is estimated that per pig 100 g of cleaned animal 
casings is produced and per sheep (goat) 75 g. This amounts to approximately 25 000 tonnes of hog 
casings  and  4 000  tonnes  of  sheep  and  goat  casings,  assuming  that  all  intestines  derived  from 
slaughtered animals are processed into animal casings. 
Part of this production (including intestines as well as bladders) is sent out of the EU for further 
processing and then re-imported as animal casings. 
According to the ENSCA Community Guide to Good Practice for hygiene and the application of the 
HACCP principles in the production of natural sausage casings, natural casings are defined as follows: 
―Natural casings are used in sausage production (and similar products referred to in section 1601 of 
the TARIC code), are derived from the intestinal tract or bladders of farm animals, have been scraped 
and cleaned and have been treated with salt (NaCl) or dried after cleaning.‖ 
The  import  of  animal  casings  into  the  EU  is  covered  by  Council  Directive  92/118/EEC  and 
Commission  Decision  2003/779/EC,  laying  down  animal  health  requirements  and  the  required 
veterinary certification for the import of animal casings from third countries. 
All  third  country  establishments  from  where  shipments  originate  have  an  implemented  HACCP 
system, are subject to FVO inspection and are approved for the import of animal casings into the EU. 
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In 2011 the following quantities of animal casings were imported into the EU from in total 29
16 
different countries (TRACES): 
  bovine casings (23 928 tonnes) 
  porcine casings (EU and non-EU origin) (43 434 tonnes) 
  ovine and caprine casings (EU and non-EU origin) (19 157 tonnes) 
  equine casings (1 152 tonnes). 
 
Some of the countries from which significant amounts of animal casings are imported into the EU are 
endemically infected with FMD with a high prevalence of disease, e.g. China, Colombia, Egypt, India, 
Iran and Pakistan. 
COMMON PRACTICES AND TREATMENTS  
In 2011, ENSCA presented their Community Guide to Good Practice for hygiene and the application 
of the HACCP principles in the production of natural sausage casings. This document was prepared in 
accordance with article 9 of Regulation (EC) No 852/2004 of the European Parliament and of the 
Council on the hygiene of foodstuffs, and it was subsequently endorsed by the Standing Committee on 
the Food Chain and Animal Health (SCOFCAH). It is available on the website of DG SANCO (link). 
Although this document is mainly intended for the European natural sausage casing industry, it is also 
used extensively by the international casing industry. Its aim is to assist in the implementation of the 
European Hygiene Package and HACCP principles according to the Codex Alimentarius 
 
                                                       
16 Albania, Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Croatia, Egypt, Iceland, India, Iran, Lebanon, 
Mongolia, Morocco, New Zealand, Pakistan, Paraguay, Peru, Russian Federation, Switzerland, Syria, Thailand, Turkey, 
Ukraine, United States of America, Uruguay, Uzbekistan. 